SCHEMBL3757538

SCHEMBL3757538

Oc1cccc(C=C(Br)Br)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.54
KDM4E B2RXH2 2/20 0.49
CCNB2 O95067 1/20 0.48
CDK1 P06493 1/20 0.48
CDK4 P11802 1/20 0.48
CCNB1 P14635 1/20 0.48
CCND1 P24385 1/20 0.48
CCNB3 Q8WWL7 1/20 0.48
CA12 O43570 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CA2 P00918 1/20 0.48
LMNA P02545 1/20 0.48
CYP3A4 P08684 1/20 0.48
CA5A P35218 1/20 0.48
CA9 Q16790 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CA14 Q9ULX7 1/20 0.48
CA5B Q9Y2D0 1/20 0.48
GFER P55789 1/20 0.47
FBP1 P09467 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3747483 0.83 LCK (0.50) LCKKDM4ECCNB2CDK1CDK4
SCHEMBL3747485 0.83 LCK (0.50) LCKKDM4ECCNB2CDK1CDK4
SCHEMBL3686105 0.79 LCK (0.56) LCKKDM4ECCNB2CDK1CDK4
SCHEMBL11044928 0.78 KDM4E (0.58) LCKKDM4ECCNB2CDK1CDK4
SCHEMBL11044925 0.78 KDM4E (0.58) LCKKDM4ECCNB2CDK1CDK4
SCHEMBL22202969 0.77 ALDH1A1 (0.56) ALDH1A1MEN1KMT2AMAPTMAOA
SCHEMBL14198007 0.77 LCK (0.54) LCKKDM4ECCNB2CDK1CDK4
SCHEMBL10888534 0.76 ALDH1A1 (0.54) KDM4ECCNB2CDK1CDK4CCNB1
SCHEMBL5364956 0.76 FBP1 (0.61) CYP3A4FBP1BLMMAOB
SCHEMBL16601893 0.76 LCK (0.52) LCKKDM4ECCNB2CDK1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4461729-A1 ANTIGEN BINDING PROTEIN TARGETING MSLN AND USE THEREOF Transthera Sciences (Nanjing), Inc. (CN) 2024-11-13 EP disclosed
CN-101888993-B Methoxyimino compounds and fungicide composition comprising same KYUNG NONG CORP 2013-08-21 CN disclosed
US-8410302-B2 Methoxyimino compounds and fungicide composition comprising same KYUNG NONG CORPORATION (KR) 2013-04-02 US disclosed
US-20100298593-A1 METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME KYUNG NONG CORPORATION (KR) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298593-A1 METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME CYP51A1, MSMO1, MTMR1 LCK 3541/4885KDM4E 143/4885CCNB2 1141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.